This content is machine translated Dyslipidemia Effective lipid management – lipid apheresis as a last resort? Current European guidelines advocate strict LDL-C lowering to prevent cardiovascular disease. Statins, which can significantly lower both total and LDL cholesterol, play a central role. In addition, PCSK9 inhibitors achieve…
View Post 5 min This content is machine translated Venous thromboembolism Clinical assessment and anticoagulant therapy – an update. If thromboembolism is not detected and treated in time, life-threatening consequences may result. Validated tests, such as the Wells score and the D-dimer test, can be used to assess the…
View Post 4 min This content is machine translated Peripheral arterial occlusive disease (pAVK) Do not trivialize “shop window disease” – counteract pAVK in good time If the calves hurt quickly even at a normal walking pace and walking breaks have to be taken repeatedly, this may be an indication of peripheral arterial occlusive disease (PAVD).…
View Post 3 min This content is machine translated High-risk cardiovascular patients. Strong reduction of LDL-C levels in daily practice achievable by combination therapies Current treatment guidelines recommend low low-density lipoprotein cholesterol (LDL-C) levels for high-risk cardiovascular patients, which are unlikely to be achieved by statin therapy alone [1,2]. The fact that cardiovascular high-risk…
View Post 17 min This content is machine translated Systemic vasculitides Therapy in the adult patient Systemic vasculitides are inflammatory syndromes of the blood vessels, which can cause a very broad spectrum of symptoms depending on the affected vessel caliber and localization. The most common primary…
View Post 7 min This content is machine translated "The lower the better" New AGLA Pocket Guide “Prevention of Atherosclerosis To reduce the risk of cardiovascular disease, low LDL-C levels are critical [1]. This finding is also reflected in the ESC/EAS Dyslipidemia Guidelines – the basis for the new Swiss…
View Post 3 min This content is machine translated Vascular Protection Prophylaxis recommended for risk factors According to current evidence, there is no statistical benefit of general routine screening. However, this does not apply in the presence of cardiovascular risk factors.
View Post 11 min This content is machine translated Vascular Surgery Therapy of peripheral vascular injuries Peripheral vascular injuries, although rare, present significant challenges. In addition to hemorrhage control, limb preservation is the primary concern.
View Post 12 min This content is machine translated Coronary heart disease Platelet aggregation inhibition after stent implantation. After stent implantation, stent thrombosis is one of the most important acute complications. Effective platelet aggregation inhibition is therefore indicated. But what does this look like?
View Post 2 min This content is machine translated Giant cell arteritis Indication expansion of Actemra® in Switzerland Until now, only high-dose steroids have been available for the potentially life-threatening autoimmune disease giant gall arteritis. This has changed with the first commercially available non-steroidal biotherapeutic targeting the IL-6…
View Post 3 min This content is machine translated Peripheral arterial occlusive disease From diagnosis to therapy – an update Unnoticed over a long period of time, peripheral arterial disease entails serious consequences. The narrowed vessels increase the risk of cardiovascular events – and life expectancy is also significantly reduced.
